CV Sciences, Inc. Quarterly Debt-to-equity in % from Q3 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CV Sciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2013 to Q3 2024.
  • CV Sciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 251 %, a 9.02% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 251 -24.9 -9.02% Sep 30, 2024
Q2 2024 222 -195 -46.8% Jun 30, 2024
Q1 2024 194 -438 -69.3% Mar 31, 2024
Q4 2023 162 -692 -81% Dec 31, 2023
Q3 2023 276 -247 -47.3% Sep 30, 2023
Q2 2023 417 +149 +55.7% Jun 30, 2023
Q1 2023 633 +427 +207% Mar 31, 2023
Q4 2022 855 +681 +393% Dec 31, 2022
Q3 2022 522 +368 +238% Sep 30, 2022
Q2 2022 268 +125 +88% Jun 30, 2022
Q1 2022 206 +81 +64.8% Mar 31, 2022
Q4 2021 173 +65.6 +60.9% Dec 31, 2021
Q3 2021 154 +62.5 +67.9% Sep 30, 2021
Q2 2021 142 +58 +68.8% Jun 30, 2021
Q1 2021 125 +54 +76% Mar 31, 2021
Q4 2020 108 +43.5 +67.5% Dec 31, 2020
Q3 2020 92 +41.1 +80.9% Sep 30, 2020
Q2 2020 84.4 +45.3 +116% Jun 30, 2020
Q1 2020 71 +38.9 +121% Mar 31, 2020
Q4 2019 64.4 +41 +175% Dec 31, 2019
Q3 2019 50.9 +24.1 +90.2% Sep 30, 2019
Q2 2019 39.1 +8.67 +28.5% Jun 30, 2019
Q1 2019 32.1 -1.55 -4.6% Mar 31, 2019
Q4 2018 23.4 -18.2 -43.8% Dec 31, 2018
Q3 2018 26.7 -15.5 -36.7% Sep 30, 2018
Q2 2018 30.5 -8.18 -21.2% Jun 30, 2018
Q1 2018 33.7 -0.7 -2.04% Mar 31, 2018
Q4 2017 41.6 +16.8 +68% Dec 31, 2017
Q3 2017 42.3 +21.9 +107% Sep 30, 2017
Q2 2017 38.6 Jun 30, 2017
Q1 2017 34.4 Mar 31, 2017
Q4 2016 24.7 Dec 31, 2016
Q3 2016 20.4 Sep 30, 2016
Q4 2014 2.68 -149 -98.2% Dec 31, 2014
Q3 2014 10.3 -206 -95.3% Sep 30, 2014
Q2 2014 22.3 Jun 30, 2014
Q1 2014 52.9 Mar 31, 2014
Q4 2013 152 Dec 31, 2013
Q3 2013 216 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.